Recent Finacing
Recent Raise
RNAimmune develops mRNA therapeutics and vaccines using Sirnaomics' Polypeptide Lipid Nanoparticle delivery and ALEPVA AI antigen‑prediction, operating discovery and IND‑enabling programs for infectious diseases, cancer, and rare diseases.
